Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Identifying aggressive prostate cancer foci using a DNA methylation classifier.

Mundbjerg K, Chopra S, Alemozaffar M, Duymich C, Lakshminarasimhan R, Nichols PW, Aron M, Siegmund KD, Ukimura O, Aron M, Stern M, Gill P, Carpten JD, Ørntoft TF, Sørensen KD, Weisenberger DJ, Jones PA, Duddalwar V, Gill I, Liang G.

Genome Biol. 2017 Jan 12;18(1):3. doi: 10.1186/s13059-016-1129-3.

2.

Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers.

Chopra S, Liu J, Alemozaffar M, Nichols PW, Aron M, Weisenberger DJ, Collings CK, Syan S, Hu B, Desai M, Aron M, Duddalwar V, Gill I, Liang G, Siegmund KD.

Oncotarget. 2017 Jan 17;8(3):5439-5448. doi: 10.18632/oncotarget.12276.

3.

Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma.

Becket E, Chopra S, Duymich CE, Lin JJ, You JS, Pandiyan K, Nichols PW, Siegmund KD, Charlet J, Weisenberger DJ, Jones PA, Liang G.

Cancer Res. 2016 Apr 1;76(7):1954-64. doi: 10.1158/0008-5472.CAN-15-2622. Epub 2016 Jan 12.

4.

The pollution removal and stormwater reduction performance of street-side bioretention basins after ten years in operation.

Lucke T, Nichols PWB.

Sci Total Environ. 2015 Dec 1;536:784-792. doi: 10.1016/j.scitotenv.2015.07.142. Epub 2015 Aug 5.

PMID:
26254078
5.

Do sediment type and test durations affect results of laboratory-based, accelerated testing studies of permeable pavement clogging?

Nichols PW, White R, Lucke T.

Sci Total Environ. 2015 Apr 1;511:786-91. doi: 10.1016/j.scitotenv.2014.12.040. Epub 2015 Jan 22.

PMID:
25618819
6.

DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.

Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G.

Hum Mol Genet. 2011 Nov 15;20(22):4299-310. doi: 10.1093/hmg/ddr356. Epub 2011 Aug 11.

7.

Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.

Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G, Nichols PW, Skinner DG, Skinner EC.

Eur Urol. 2011 Nov;60(5):946-52. doi: 10.1016/j.eururo.2011.07.012. Epub 2011 Jul 14.

PMID:
21802833
8.

Diagnostic radiography and adult acute myeloid leukaemia: an interview and medical chart review study.

Pogoda JM, Nichols PW, Ross RK, Stram DO, Thomas DC, Preston-Martin S.

Br J Cancer. 2011 Apr 26;104(9):1482-6. doi: 10.1038/bjc.2011.114.

9.

Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.

Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G.

PLoS Genet. 2010 Apr 22;6(4):e1000917. doi: 10.1371/journal.pgen.1000917.

10.

Urethral recurrence in a woman after continent orthotopic urinary diversion for bladder cancer.

Stein JP, Hertz J, Nichols PW.

Urology. 2008 Apr;71(4):755.e1-2. doi: 10.1016/j.urology.2007.11.068. Epub 2008 Feb 15.

PMID:
18280556
11.

Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.

Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG.

J Urol. 2005 Jul;174(1):103-6.

PMID:
15947587
12.

Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience.

Quek ML, Nichols PW, Yamzon J, Daneshmand S, Miranda G, Cai J, Groshen S, Stein JP, Skinner DG.

J Urol. 2005 Jul;174(1):93-6.

PMID:
15947585
13.

Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue.

Daneshmand S, Dorff TB, Quek ML, Cai J, Pike MC, Nichols PW, Pinski J.

Urology. 2005 May;65(5):1008-12.

PMID:
15882754
14.

Prescription drug use and risk of acute myeloid leukemia by French-American-British subtype: results from a Los Angeles County case-control study.

Pogoda JM, Katz J, McKean-Cowdin R, Nichols PW, Ross RK, Preston-Martin S.

Int J Cancer. 2005 Apr 20;114(4):634-8.

15.

Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.

Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G.

Clin Cancer Res. 2004 Nov 15;10(22):7457-65.

16.
17.

Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.

Daneshmand S, Stein JP, Lesser T, Quek ML, Nichols PW, Miranda G, Cai J, Groshen S, Skinner EC, Skinner DG.

J Urol. 2004 Jul;172(1):81-4.

PMID:
15201742
18.

Smoking and risk of acute myeloid leukemia: results from a Los Angeles County case-control study.

Pogoda JM, Preston-Martin S, Nichols PW, Ross RK.

Am J Epidemiol. 2002 Mar 15;155(6):546-53.

PMID:
11882528
19.

Diagnostic 'individuality'.

Nichols PW, Cote RJ.

Am J Surg Pathol. 2001 Aug;25(8):1100; author reply 1104-6. No abstract available.

PMID:
11474298
20.

Progressive increases in de novo methylation of CpG islands in bladder cancer.

Salem C, Liang G, Tsai YC, Coulter J, Knowles MA, Feng AC, Groshen S, Nichols PW, Jones PA.

Cancer Res. 2000 May 1;60(9):2473-6.

21.

Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers.

Nguyen TT, Nguyen CT, Gonzales FA, Nichols PW, Yu MC, Jones PA.

Prostate. 2000 May 15;43(3):233-42.

PMID:
10797499
22.

Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications.

Nguyen TT, Mohrbacher AF, Tsai YC, Groffen J, Heisterkamp N, Nichols PW, Yu MC, Lübbert M, Jones PA.

Blood. 2000 May 1;95(9):2990-2.

23.

Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5alpha-reductase during prostate cancer progression.

Akalu A, Dlmajian DA, Highshaw RA, Nichols PW, Reichardt JK.

J Urol. 1999 Apr;161(4):1355-8.

PMID:
10081907
24.

Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.

Tsutsumi M, Tsai YC, Gonzalgo ML, Nichols PW, Jones PA.

Oncogene. 1998 Dec 10;17(23):3021-7.

25.

Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer.

Bochner BH, Esrig D, Groshen S, Dickinson M, Weidner N, Nichols PW, Skinner DG, Cote RJ.

Clin Cancer Res. 1997 Sep;3(9):1615-22.

26.

DNA methylation differences associated with tumor tissues identified by genome scanning analysis.

Liang G, Salem CE, Yu MC, Nguyen HD, Gonzales FA, Nguyen TT, Nichols PW, Jones PA.

Genomics. 1998 Nov 1;53(3):260-8.

PMID:
9799591
27.

p53 protein and gene alterations in pathological stage C prostate carcinoma.

Salem CE, Tomasic NA, Elmajian DA, Esrig D, Nichols PW, Taylor CR, Skinner DG, Roy-Burman P, Lieskovsky G, Cote RJ.

J Urol. 1997 Aug;158(2):510-4.

PMID:
9224335
28.

Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.

Van Tornout JM, Spruck CH 3rd, Shibata A, Schmutte C, Gonzalez-Zulueta M, Nichols PW, Chandrasoma PT, Yu MC, Jones PA.

Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):493-7.

29.

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.

Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG, Cote RJ.

J Natl Cancer Inst. 1997 Feb 5;89(3):219-27.

PMID:
9017002
30.

Contiguous patches of normal human mammary epithelium derived from a single stem cell: implications for breast carcinogenesis.

Tsai YC, Lu Y, Nichols PW, Zlotnikov G, Jones PA, Smith HS.

Cancer Res. 1996 Jan 15;56(2):402-4.

31.

High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia.

Douer D, Preston-Martin S, Chang E, Nichols PW, Watkins KJ, Levine AM.

Blood. 1996 Jan 1;87(1):308-13.

32.

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW.

J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12.

PMID:
7563203
33.

High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.

Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH 3rd, Busch C, Shamaa M, El-Baz M, Nichols PW, Gonzalgo ML, Elbaz M [corrected to El-Baz M], et al.

J Natl Cancer Inst. 1995 Sep 20;87(18):1383-93. Erratum in: J Natl Cancer Inst 1995 Dec 6;87(23):1807.

PMID:
7658499
34.

Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium.

Tsai YC, Simoneau AR, Spruck CH 3rd, Nichols PW, Steven K, Buckley JD, Jones PA.

J Urol. 1995 May;153(5):1697-700.

PMID:
7715013
35.
36.

Accumulation of nuclear p53 and tumor progression in bladder cancer.

Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ.

N Engl J Med. 1994 Nov 10;331(19):1259-64.

37.

Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan.

Shibata A, Ohneseit PF, Tsai YC, Spruck CH 3rd, Nichols PW, Chiang HS, Lai MK, Jones PA.

Carcinogenesis. 1994 Jun;15(6):1085-7.

PMID:
8020137
38.

Microsatellite instability in bladder cancer.

Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai YC, Spruck CH 3rd, Miyao N, Nichols PW, Hermann GG, Horn T, Steven K, et al.

Cancer Res. 1993 Dec 1;53(23):5620-3.

39.

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.

Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ.

Am J Pathol. 1993 Nov;143(5):1389-97.

40.
41.

Role of chromosome 9 in human bladder cancer.

Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH 3rd, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA.

Cancer Res. 1993 Sep 1;53(17):4066-70.

42.

Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.

Spruck CH 3rd, Rideout WM 3rd, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, Steven K, et al.

Cancer Res. 1993 Mar 1;53(5):1162-6. Erratum in: Cancer Res 1993 May 15;53(10 Suppl):2427.

43.

Pulmonary clearance of Mycoplasma pulmonis in rats with respiratory viral infections or of susceptible genotype.

Nichols PW, Schoeb TR, Davis JK, Davidson MK, Lindsey JR.

Lab Anim Sci. 1992 Oct;42(5):454-7.

PMID:
1460843
44.

Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction.

Shibata D, Hawes D, Li ZH, Hernandez AM, Spruck CH, Nichols PW.

Am J Pathol. 1992 Sep;141(3):539-43.

45.

Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder.

Olumi AF, Tsai YC, Nichols PW, Skinner DG, Cain DR, Bender LI, Jones PA.

Cancer Res. 1990 Nov 1;50(21):7081-3.

46.

Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.

Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, Jones PA.

Cancer Res. 1990 Jan 1;50(1):44-7.

PMID:
2293558
47.

Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish.

Yu MC, Nichols PW, Zou XN, Estes J, Henderson BE.

Br J Cancer. 1989 Aug;60(2):198-201.

48.

A clinical, histopathologic, and electron microscopic study of Pneumocystis carinii choroiditis.

Rao NA, Zimmerman PL, Boyer D, Biswas J, Causey D, Beniz J, Nichols PW.

Am J Ophthalmol. 1989 Mar 15;107(3):218-28.

PMID:
2784287
49.

Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.

Fitzgibbons PL, Chaurushiya PS, Nichols PW, Chandrasoma PT, Martin SE.

Hum Pathol. 1989 Mar;20(3):269-72.

PMID:
2722176
50.

Analysis of somatic changes in human tumor DNA using synthetic oligonucleotide probes.

Parimoo S, Bachman BA, Kumar D, Nichols PW, Wallace RB, Roy-Burman P.

Cancer Commun. 1989;1(5):293-9.

PMID:
2702036

Supplemental Content

Loading ...
Support Center